EMA Authorised: Rezolsta (darunavir;cobicistat) — Janssen-Cilag International N.V.

View source ↗

Summary

EMA authorised Rezolsta (darunavir/cobicistat) for HIV infections, a fixed-dose combination co-formulated by Janssen-Cilag International N.V.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Rezolsta (darunavir/cobicistat)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Janssen-Cilag International N.V.. Decision date: 18/07/2025